Who invested in Lycia Therapeutics

2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 5 months ago

Funding summaryUpdated 26 Oct 2026

$182Mraised across 2 rounds since 2024, from 2 sources

$107MSeries C$75MSeries D

Latest round: Series D, $75MJun 2026
Biggest round: $107MSeries C · May 2024
Investors: 6

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20252026

$107MSeries C$75MSeries D

First round: Series C, $107M
Biggest round: $107M
Between rounds: 2.1 years

The rounds

Jun 2026
Series D$75M1 new3 returning
Source recordedSEC filing: $75M sold
May 2024
Series C$107M5 new
Source recordedSEC filing: $107M sold, first sale Apr 2024

Founders and team

From Lycia Therapeutics's own website: 3 on the team.

Winsome ChungSenior Vice President, Finance
Amy BachrodtChief Financial Officer
William J. RieflinChair, Lycia Therapeutics

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series C2024Series D2026

Franklin Templeton

Janus Henderson Investors

Everyone who backed them

Franklin TempletonPrivate equity2rounds

Janus Henderson InvestorsPrivate equity2rounds

Eli LillyCorporate VC2rounds

Redmile GroupVC firm1round

RTW Investments LLCGrowth equity1round

Blue OwlAsset manager1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Lycia Therapeutics

Who invested in Lycia Therapeutics?

Lycia Therapeutics's investors include Franklin Templeton, Janus Henderson Investors, Eli Lilly, Redmile Group and RTW Investments LLC, and 1 more on record.